Researchers at Michigan Medicine and the Cleveland Clinic believe a newly designed blood test will help people with irritable ...

Study reveals how a new IgE antibody therapy reactivates immune cells, offering a promising approach to fighting ovarian ...

The global antibody discovery market size is anticipated to reach approximately USD 22,570 million by 2034, up from USD 9,570 ...

Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.

With an arsenal of antibody assets based on IgE, IgA, and IgG, the newly combined company has opportunities across cancer indications.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

The FDA has approved Uplizna (inebilizumab-cdon) for the treatment of immunoglobulin G4-related disease in adult patients.

UPPSALA, Sweden, April 10, 2025 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces positive in-vivo proof-of-concept data for a powder-based intranasal vaccine candidate ...

In many cases, what seems like weight gain might be inflammation-driven swelling and not additional fat. Identifying and ...

Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more ...

J&J exhibited additional findings, displaying that nipocalimab met its key secondary endpoint, a change in QMG score.